Cryoport CYRX
$19.10 +$3.05 (+19.00%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $19.00 -0.52%
Open$17.50
Prev close$16.05
Day range$17.17 – $19.53
Volume2.59M
Market cap$968.38M
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±13.6%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+30.6%
Worst reaction-32.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±12.1% | +2.79% | Within range |
| 2026/Q1 | 4 May 2026 | After Market | ±14.3% | +19.39% | Bigger than priced |
| 2025/Q4 | 3 Mar 2026 | After Market | ±20.6% | +2.94% | Within range |
| 2025/Q3 | 4 Nov 2025 | After Market | ±17.0% | -7.48% | Within range |
| 2025/Q2 | 5 Aug 2025 | After Market | ±21.0% | +29.82% | Bigger than priced |
| 2025/Q1 | 7 May 2025 | After Market | ±34.1% | +23.32% | Within range |
| 2024/Q4 | 4 Mar 2025 | After Market | ±18.8% | +30.63% | Bigger than priced |
| 2024/Q3 | 7 Nov 2024 | After Market | ±16.2% | -3.62% | Within range |
| 2024/Q2 | 6 Aug 2024 | After Market | ±28.3% | -0.26% | Within range |
| 2024/Q1 | 7 May 2024 | After Market | ±17.5% | -19.51% | Bigger than priced |
| 2023/Q4 | 12 Mar 2024 | After Market | ±16.1% | -11.90% | Within range |
| 2023/Q3 | 8 Nov 2023 | After Market | ±29.7% | +10.03% | Within range |
| 2023/Q2 | 9 Aug 2023 | After Market | ±18.2% | -1.76% | Within range |
| 2023/Q1 | 4 May 2023 | After Market | ±24.2% | +13.71% | Within range |
| 2022/Q4 | 23 Feb 2023 | After Market | ±18.4% | +8.79% | Within range |
| 2022/Q3 | 3 Nov 2022 | After Market | ±16.2% | -32.05% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q2
By business line
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$48.97M+7.7% YoY
Operating profit-$10.04M-4.0% YoY
Net profit-$8.26M-107.6% YoY
Diluted EPS-$0.20-109.4% YoY
Free cash flow-$8.68M+35.9% YoY
Operating cash flow$1.13M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin47.1%
Operating margin-21.2%
Net margin-24.3%
Return on equity-9.9%
Return on assets-5.9%
Return on invested capital-6.4%
Current ratio2.08
Liabilities / assets35.1%
Cash & investments$396.69M
Total debt$227.63M
Net cash (debt)$169.06M
No comments yet — be the first to weigh in on CYRX.